Adaptimmune Therapeutics PLC (ADAPY): Operating Income
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
-$68.76M
Year ended 2024-12-31
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | -$68.76M | n/m | 2025-03-24, From 2024-01-01 |
| 2023-12-31 | -$139.74M | n/m | 2025-03-24, From 2023-01-01 |
| 2022-12-31 | -$163.97M | n/m | 2025-03-24, From 2022-01-01 |
| 2021-12-31 | -$162.25M | n/m | 2024-03-06, From 2021-01-01 |
| 2020-12-31 | -$133.41M | n/m | 2023-03-06, From 2020-01-01 |
| 2019-12-31 | -$139.77M | n/m | 2022-03-14, From 2019-01-01 |
| 2018-12-31 | -$82.36M | n/m | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | -$80.66M | n/m | 2019-02-27, From 2017-01-01 |
| 2016-12-31 | -$72.80M | n/a | 2019-02-27, From 2016-01-01 |
| No annual figure between 2015-06-30 and 2016-12-31. | |||
| 2015-06-30 | -$24.64M | n/m | 2018-03-15, From 2014-07-01 |
| 2014-06-30 | -$11.52M | n/a | 2017-03-13, From 2013-07-01 |